Division of Thermo Fisher Scientific Inc.
Latest From Protometrix Inc.
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups feature companies involved in Congestive Heart Failure Devices, Pain Therapeutics, and Protein-Based Drug Discovery. Plus these selected Start-Ups across Health Care: Enanta Pharmaceuticals Inc., etrials Inc. and Organ Recovery Systems Inc.
Protometrix's microarray technology enables it to produce, purify, and assay thousands of proteins at once on a solid surface. With this skill set, the company believes it can become the first firm able to offer drug developers the ability to scan the entire human proteome in a high-throughput setting.
For more than a year, VCs have backed away from the proteomics tools group--drug companies hadn't signed the expected number and value of deals with them, and it was deal revenues that were, according to most business plans, going to support these start-ups. That pharma and biotech companies have a bigger appetite for products than for platform technology has become a truism. Licensors increasingly are finding that they must offer partners more than a discovery technology platform-either by validating targets and building value before out-licensing, or at least having the biological capability in-house to be a true collaborator.
Drug Discovery Tools
- Nanotechnology, Chips, etc.
- Drug Discovery Tools
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Thermo Fisher Scientific Inc.
- Senior Management
Hollis D Kleinert, Pres. & CEO
Paul F Predki, VP, R&D
- Contact Info
Phone: (203) 458-5868
66 High St.
Guilford, CT 06437
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.